Using markov model to cost-effectiveness analysis of traditional Chinese medicine interference.
- Author:
Nuo WANG
1
;
Zhan-Jun ZHANG
;
Dong CHANG
Author Information
1. Economy and resource management research institute, Beijing Normal University, Beijing 100875, China. wangnuo@bnu.edu.cn
- Publication Type:Journal Article
- MeSH:
Alzheimer Disease;
drug therapy;
economics;
Cognitive Dysfunction;
drug therapy;
economics;
Cost-Benefit Analysis;
Drugs, Chinese Herbal;
economics;
therapeutic use;
Humans;
Markov Chains;
Medicine, Chinese Traditional;
economics
- From:
China Journal of Chinese Materia Medica
2012;37(18):2698-2701
- CountryChina
- Language:Chinese
-
Abstract:
Mild cognitive impairment (MCI) is the transition state between normal aging and AD. There are better detection and treatment methods to screen a population of patients with MCI. Through intervention, the probability of MCI conversion to AD can be significantly reduced. This paper first introduces the concept of cost-effectiveness analysis, reconsiders the concept of cost for the particularity of MCI, and uses QALY to evaluate the health effects of the quality of life. Then measure the health quality of life of elderly MCI population, and use Markov model to study the cost of intervention with traditional Chinese medicine-effectiveness analysis. Finally, according to the QALY measure and CEA results, we draw the conclusion that it's helpful to get early intervention in MCI.
